Chien‐Tung Wu

463 citations
18 papers · 368 indexed · h-index 12
Topics
Estrogen and related hormone effects (5 papers)Cancer Risks and Factors (4 papers)Complementary and Alternative Medicine Studies (4 papers)
Partner nations
Taiwan

In The Last Decade

Chien‐Tung Wu

18 papers receiving 348 citations

Peers

Chien‐Tung Wu
Comparison fields: 5 of 71
  • Complementary and alternative medicine 109
  • Molecular Biology 101
  • Pharmacology 70
  • Oncology 55
  • Endocrinology, Diabetes and Metabolism 55
Replace Hoda Atef with:
Hoda Atef Egypt
Gaohong Lv China
Sarita Aggarwal India
Mine Yavuz Taşlıpınar Türkiye
Soo Yeon Kang South Korea
Jingwei Zhou China
Xun Jin China
Guijiang Sun China
Xiaoyan Yang China
A O Olukoga United Kingdom
Chien‐Tung Wu relative to Hoda Atef Egypt Hoda Atef's profile →
Citations per field
00.5×10×14.3×
Hoda Atef · 1×
Citations per year

Countries citing papers authored by Chien‐Tung Wu

Since Specialization
Citations

This map shows the geographic impact of Chien‐Tung Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Tung Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Tung Wu more than expected).

Fields of papers citing papers by Chien‐Tung Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Tung Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Tung Wu. The network helps show where Chien‐Tung Wu may publish in the future.

Co-authorship network of co-authors of Chien‐Tung Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Tung Wu. A scholar is included among the top collaborators of Chien‐Tung Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Tung Wu. Chien‐Tung Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 3
2 3
3 2
4 2
5 25
6 14
7 15
8 15
9 12
10 70
11 18
12 8
13 24
14 30
15 10
16 37
17 64
18 16

About Chien‐Tung Wu

Chien‐Tung Wu is a scholar working on Complementary and alternative medicine, Obstetrics and Gynecology and Pharmacology, having authored 18 papers that have together received 368 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (5 papers), Cancer Risks and Factors (4 papers) and Complementary and Alternative Medicine Studies (4 papers). The work is most often cited by research in Complementary and alternative medicine (109 citations), Pharmacology (70 citations) and Reproductive Medicine (39 citations). Chien‐Tung Wu has collaborated with scholars based in Taiwan. Frequent co-authors include Jung‐Nien Lai, Yueh‐Ting Tsai, Jung‐Der Wang, Shun‐Ku Lin, Chung‐Yu Huang, Jung‐Nien Lai, Chen-Chang Yang, Jiun‐Lu Lin, Shu‐Ling Fu and Chao A. Hsiung. Their work appears in journals such as PLoS ONE, Journal of Ethnopharmacology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026